The Journal of Organic Chemistry
Article
193.7, 169.2, 142.0, 134.7, 128.7, 116.9, 87.2, 77.7, 73.9, 70.0, 20.8,
14.3. HRMS (ESI/LTQ) m/z: [M + Na]+ calcd for C12H16O5Na
263.0890; found 263.0892.
mmol) in CH2Cl2 (3.0 mL) for 50 min. Purification by silica gel
column chromatography (10% EtOAc/hexanes) afforded a mixture of
diastereomers of acetoxypyranone 14h (163 mg, 64% yield over 2
steps) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.94−6.86 (m,
1H), 6.53 (d, J = 3.7 Hz, 1H), 6.21−6.13 (m, 1H), 5.83−5.65 (m,
1H), 4.94−4.85 (m, 2H), 4.29−4.23 (m, 1H), 4.08 (dd, J = 7.0, 2.8
Hz, 1H), 3.56−3.38 (m, 2H), 2.07 (d, J = 1.3 Hz, 3H), 2.03−1.93 (m,
2H), 1.66−1.58 (m, 2H), 1.24 (d, J = 6.5 Hz, 3H). 13C{1H} NMR
(100 MHz, CDCl3) δ 193.8, 169.1, 142.3, 138.1, 129. 1, 114.6, 87.2,
79.7, 74.2, 68.4, 30.1, 28.8, 20.8, 15.2. HRMS (ESI/LTQ) m/z: [M +
Na]+ calcd for C14H20O5Na 291.0203; found 291.0207.
General Procedure G: Synthesis of the Cycloadducts 16a−
h. To a stirred solution of the acetoxypyranone (1.0 equiv) in
CH3CN (0.02 M) at 23 °C was added N-methylpyrrolidine (4.0
equiv), and the resulting mixture was heated to 60−150 °C in an oil
bath. After 3−24 h, the mixture was concentrated, and the residue was
purified by silica gel column chromatography afforded the desired
cycloadduct.
(3S,3aS,7S,8aS)-3-Phenyl-1,7,8,8a-tetrahydro-3H,4H-3a,7-
epoxycyclohepta[c]furan-4-one (16a). The reaction was conducted
according to the general procedure G with acetoxypyranone 14a (100
mg, 0.33 mmol) and N-methylpyrrolidine (138 μL, 1.32 mmol) in
CH3CN (12.7 mL) at 60 °C for 12 h. Purification by silica gel column
chromatography (20% EtOAc/hexanes) afforded the cycloadduct 16a
(71 mg, 89% yield, dr = 10:1) as a crystalline white solid. The purified
compound was dissolved in ethyl acetate and hexanes and was
allowed to crystallize at 23 °C for 5 days. 1H NMR (800 MHz,
CDCl3) δ 7.47 (d, J = 7.4 Hz, 2H), 7.37−7.26 (m, 3H), 7.15 (dd, J =
9.7, 4.3 Hz, 1H), 6.01 (d, J = 9.7 Hz, 1H), 5.56 (s, 1H), 5.05−4.98
(m, 1H), 4.22 (t, J = 8.6 Hz, 1H), 4.08 (dd, J = 9.3, 3.4 Hz, 1H),
2.97−2.89 (m, 1H), 2.33 (dd, J = 12.1, 8.9 Hz, 1H), 2.16 (dt, J = 12.0,
6.1 Hz, 1H). 13C{1H} NMR (200 MHz, CDCl3) δ 194.9, 151.8,
135.6, 127.8, 127.8, 126.7, 126.7, 97.7, 80.0, 76.7, 71.9, 46.5, 36.4.
HRMS (APCI/LTQ) m/z: [M + H]+ calcd for C15H15O3 243.1016;
found 243.1014.
6-((S)-(But-3-en-1-yloxy)(phenyl)methyl)-5-oxo-5,6-dihydro-2H-
pyran-2-yl Acetate (14e). The reaction was conducted according to
the general procedure G with furfuryl alcohol 13e (50 mg, 0.19
mmol), KBr (2.5 mg, 0.02 mmol), NaHCO3 (8.2 mg, 0.1 mmol), and
oxone (145 mg, 0.23 mmol) to afford the desired hydroxypyranone.
The acetylation reaction was conducted according to the general
procedure using the crude hydroxypyranone(53 mg, 0.19 mmol),
pyridine (25 μL, 0.29 mmol), and acetyl chloride (20 μL, 0.29 mmol)
in CH2Cl2 (1.0 mL) for 3 h. Purification by silica gel column
chromatography (15% EtOAc/hexanes) afforded a separable mixture
of anti/syn-acetoxypyranone 14e (36 mg, 60% yield over 2 steps) as a
colorless oil in 3:1 diastereomeric ratio. anti-Acetoxypyranone 14e:
1H NMR (400 MHz, CDCl3) δ 7.36−7.21 (m, 5H), 6.79 (dd, J =
10.3, 3.6 Hz, 1H), 6.48 (dd, J = 3.6, 0.6 Hz, 1H), 6.06 (dd, J = 10.3,
0.7 Hz, 1H), 5.79 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.10−4.97 (m,
3H), 4.92 (d, J = 2.8 Hz, 1H), 3.45 (ddt, J = 32.7, 9.3, 6.8 Hz, 2H),
2.35 (dq, J = 7.0, 1.5 Hz, 2H), 2.11 (s, 3H). 13C{1H} NMR (100
MHz, CDCl3) δ 192.8, 169.3, 141.9, 136.3, 134.9, 128.6, 128.3, 127.9,
127.8, 116.4, 87.3, 80.5, 79.4, 68.8, 34.0, 20.9. HRMS (ESI/LTQ) m/
z: [M + Na]+ calcd for C18H20O5Na 339.1203; found 339.1208.
6-((S)-1-(But-3-en-1-yloxy)-2-methylpropyl)-5-oxo-5,6-dihydro-
2H-pyran-2-yl Acetate (14f). The reaction was conducted according
to the general procedure G with furfuryl alcohol 13f (100 mg, 0.45
mmol), KBr (5.0 mg, 0.04 mmol), NaHCO3 (19.0 mg, 0.22 mmol),
and oxone (330 mg, 0.54 mmol) to afford the desired hydroxypyr-
anone. The acetylation reaction was conducted according to the
general procedure using the crude hydroxypyranone (107 mg, 0.45
mmol), pyridine (78 μL, 0.89 mmol), and acetyl chloride (48 μL, 0.67
mmol) in CH2Cl2 (1.5 mL) for 30 min. Purification by silica gel
column chromatography (15% EtOAc/hexanes) afforded a mixture of
diastereomers of acetoxypyranone 14f (82 mg, 65% yield over 2
steps) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.91 (d, J = 3.7
Hz, 1H), 6.58−6.52 (m, 1H), 6.28−6.18 (m, 1H), 5.88−5.75 (m,
1H), 5.14−5.01 (m, 2H), 4.69 (d, J = 2.1 Hz, 1H), 3.72−3.64 (m,
1H), 3.48−3.40 (m, 2H), 2.34−2.28 (m, 2H), 2.24−2.19 (m, 1H),
2.14 (s, 3H), 1.10−0.86 (m, 6H, superimposed by peak
corresponding to the minor isomer). 13C{1H} NMR (100 MHz,
CDCl3) δ 193.7, 169.2, 140.9, 135.2, 128.8, 116.1, 87.7, 84.9, 79.0,
70.6, 34.3, 29.4, 20.7, 19.7, 19.2. HRMS (ESI/Q-TOF) m/z: [M +
Na]+ calcd for C15H22O5Na 305.1360; found 305.1357.
(3R,3aR,7R,8aR)-3-Phenyl-1,7,8,8a-tetrahydro-3H,4H-3a,7-
epoxycyclohepta[c]furan-4-one (16b). The reaction was conducted
according to the general procedure G with acetoxypyranone 14b (170
mg, 0.56 mmol) and N-methylpyrrolidine (235 μL, 2.25 mmol) in
CH3CN (22 mL) at 60 °C for 12 h. Purification by silica gel column
chromatography (20% EtOAc/hexanes) afforded the cycloadduct 16b
(100 mg, 74% yield, dr = 10:1) as a crystalline white solid. The
purified compound was dissolved in ethyl acetate and hexanes and
1
was allowed to crystallize at 23 °C for 5 days. H NMR (800 MHz,
6-((S)-1-(But-3-en-1-yloxy)ethyl)-5-oxo-5,6-dihydro-2H-pyran-2-
yl Acetate (14g). The reaction was conducted according to the
general procedure G with furfuryl alcohol 13g (55 mg, 0.28 mmol),
KBr (4 mg, 0.03 mmol), NaHCO3 (12 mg, 0.14 mmol), and oxone
(210 mg, 0.34 mmol) to afford the desired hydroxypyranone. The
acetylation reaction was conducted according to the general
procedure using the crude hydroxypyranone (59 mg, 0.28 mmol),
pyridine (50 μL, 0.55 mmol), and acetyl chloride (30 μL, 0.41 mmol)
in CH2Cl2 (1.0 mL) for 40 min. Purification by silica gel column
chromatography (10% EtOAc/hexanes) afforded a mixture of
diastereomers of acetoxypyranone 14g (53 mg, 75% yield over 2
steps) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.94−6.88 (m,
1H), 6.63 (dd, J = 3.4, 0.7 Hz, 1H), 6.22−6.15 (m, 1H), 5.86−5.72
(m, 1H), 5.11−4.91 (m, 2H), 4.29−4.26 (m, 1H), 4.14−4.09 (m,
1H), 3.58−3.50 (m, 2H), 2.24−2.18 (m, 2H), 2.09 (s, 3H), 1.28 (d, J
= 6.5 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 193.8, 169.1,
142.3, 134.9, 129.2, 116.2, 87.3, 79.8, 74.4, 69.3, 34.1, 20.8, 15.2.
HRMS (ESI/LTQ) m/z: [M + Na]+ calcd for C13H18O5Na 277.1046;
found 277.1050.
5-Oxo-6-((S)-1-(pent-4-en-1-yloxy)ethyl)-5,6-dihydro-2H-pyran-
2-yl Acetate (14h). The reaction was conducted according to the
general procedure G with furfuryl alcohol 13h (200 mg, 0.95 mmol),
KBr (11.0 mg, 0.1 mmol), NaHCO3 (40.0 mg, 0.48 mmol), and
oxone (700 mg, 1.14 mmol) to afford the desired hydroxypyranone.
The acetylation reaction was conducted according to the general
procedure using the crude hydroxypyranone (215 mg, 0.95 mmol),
pyridine (170 μL, 1.90 mmol), and acetyl chloride (100 μL, 1.43
CDCl3) δ 7.47 (d, J = 7.6 Hz, 2H), 7.36−7.26 (m, 3H), 7.15 (dd, J =
9.7, 4.3 Hz, 1H), 6.01 (d, J = 9.7 Hz, 1H), 5.56 (s, 1H), 5.02 (dd, J =
6.7, 4.2 Hz, 1H), 4.22 (t, J = 8.7 Hz, 1H), 4.08 (dd, J = 9.2, 3.4 Hz,
1H), 2.96−2.90 (m, 1H), 2.33 (dd, J = 12.0, 8.9 Hz, 1H), 2.16 (dt, J =
12.3, 6.3 Hz, 1H). 13C{1H} NMR (100 MHz, CDCl3) δ 194.9, 151.8,
135.6, 127.8, 127.8, 126.7, 126.7, 97.7, 80.0, 76.7, 71.9, 46.5, 36.4.
HRMS (APCI/LTQ) m/z: [M + H]+ calcd for C15H15O3 243.1016;
found 243.1018.
(3S,3aS,7S,8aS)-3-isopropyl-1,7,8,8a-tetrahydro-3H,4H-3a,7-
epoxycyclohepta[c]furan-4-one (16c). The reaction was conducted
according to the general procedure G with acetoxypyranone 14c (190
mg, 0.71 mmol) and N-methylpyrrolidine (295 μL, 1.41 mmol) in
CH3CN (27 mL) at 60 °C for 12 h. Purification by silica gel column
chromatography (15% EtOAc/hexanes) afforded the cycloadduct 16c
24
(129 mg, 88% yield, dr = 2:1) as a yellow oil. 16c (major): [α]D
1
+38.6 (c 0.3, CHCl3). H NMR (400 MHz, CDCl3) δ 7.17 (dd, J =
9.8, 4.3 Hz, 1H), 5.98 (d, J = 9.8 Hz, 1H), 5.01 (dd, J = 6.6, 4.3 Hz,
1H), 4.01−3.93 (m, 2H), 3.84 (dd, J = 9.2, 3.2 Hz, 1H), 2.74−2.66
(m, 1H), 2.22 (dd, J = 12.0, 8.9 Hz, 1H), 2.05−1.90 (m, 2H), 1.06 (d,
J = 6.6 Hz, 3H), 0.84 (d, J = 6.8 Hz, 3H). 13C{1H} NMR (100 MHz,
CDCl3) δ 195.4, 151.6, 126.7, 96.8, 84.6, 76.4, 71.4, 47.2, 36.2, 28.0,
24
1
20.3, 19.1. 16c (minor): [α]D −116.4 (c 0.2, CHCl3). H NMR
(400 MHz, CDCl3) δ 7.16 (dd, J = 9.7, 4.4 Hz, 1H), 6.00 (d, J = 9.5
Hz, 1H), 5.11 (d, J = 4.9 Hz, 1H), 4.29 (t, J = 8.2 Hz, 1H), 3.44 (t, J =
9.1 Hz, 1H), 3.28 (d, J = 10.4 Hz, 1H), 2.82 (dp, J = 9.6, 6.4 Hz, 1H),
2.66 (p, J = 7.8 Hz, 1H), 1.93 (t, J = 5.4 Hz, 2H), 1.01 (d, J = 6.6 Hz,
8139
J. Org. Chem. 2021, 86, 8127−8142